71 related articles for article (PubMed ID: 21963993)
1. Hepatitis B and C virus prevalence and related factors in patients with inflammatory bowel diseases.
Yakut M; Kabaçam G; Üstün Y; Cetinkaya H; Soykan I
Clin Res Hepatol Gastroenterol; 2011 Dec; 35(12):857. PubMed ID: 21963993
[No Abstract] [Full Text] [Related]
2. [Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors].
Longo F; Hebuterne X; Tran A; Staccini P; Hastier P; Schneider S; Benzaken S; Tirtaine C; Rampal P
Gastroenterol Clin Biol; 2000 Jan; 24(1):77-81. PubMed ID: 10679588
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and hepatitis B and C.
Chevaux JB; Bigard MA; Bensenane M; Oussalah A; Jarlot S; Belle A; Nani A; Bronowicki JP; Peyrin-Biroulet L
Gastroenterol Clin Biol; 2009 Dec; 33(12):1082-93. PubMed ID: 19896313
[TBL] [Abstract][Full Text] [Related]
5. [HCV antibodies in hemodialyzed patients in Tunisia].
Hmida S; Mojaat N; Chaouchi E; Mahjoub T; Khlass B; Abid S; Boukef K
Pathol Biol (Paris); 1995 Sep; 43(7):581-3. PubMed ID: 8570261
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis B (HBV) and C (HCV) virus infections as an eventual cause of chronic hepatic damage in patients undergoing maintenance hemodialysis ].
Slizien W; Michalik D; Własiuk M; Rutkowski B; Brylowska A
Przegl Lek; 1995; 52(2):47-50. PubMed ID: 7784615
[TBL] [Abstract][Full Text] [Related]
9. Questions regarding use of infliximab and risk of certain viral infections.
El-Matary W
Am J Gastroenterol; 2009 Nov; 104(11):2852; author reply 2852-3. PubMed ID: 19888241
[No Abstract] [Full Text] [Related]
10. [Early decline in an epidemic: evolution of the prevalences of HIV, hepatitis B, hepatitis C and aminotransferases in intravenous drug abusers in Strasbourg between 1980 and 1990].
Will T
Rev Med Suisse Romande; 1999 Apr; 119(4):329-34. PubMed ID: 10361471
[TBL] [Abstract][Full Text] [Related]
11. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
[TBL] [Abstract][Full Text] [Related]
12. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B virus and hepatitis C virus in health workers in 3 major hospitals in Aden, Republic of Yemen.
Al-Jarba AS; Al-Sayyari WM
Saudi Med J; 2003 Sep; 24(9):1031-2. PubMed ID: 12973499
[No Abstract] [Full Text] [Related]
14. Inflammatory bowel diseases and hepatitis C virus infection.
Li YD; Lin JJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):398-401. PubMed ID: 20688604
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis: the etiological spectrum. The implications for treatment].
Velosa J; Ramalho F; Serejo F; Marinho R; de Moura MC
Acta Med Port; 1993 Jun; 6(6):233-8. PubMed ID: 8368089
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B and C markers in patients on maintenance hemodialysis in Najran.
Khan LA; Khan SA
Saudi Med J; 2001 Jul; 22(7):641-2. PubMed ID: 11479651
[No Abstract] [Full Text] [Related]
17. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
18. National surveillance of dialysis associated diseases in the United States, 1993.
Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
[TBL] [Abstract][Full Text] [Related]
19. Viral hepatitis in the Christchurch community.
Chapman BA; Hann DJ; Schousboe MI; Burt MJ; Wilkinson ID; George PM
N Z Med J; 1992 Sep; 105(942):376-7. PubMed ID: 1436840
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and C virus markers among the members of the medical-sanitary staff from the Faculty of Dentistry "Carol Davila" University of Medicine and Pharmacy, Bucharest.
Bălteanu M; Butur D; Iliescu S; Lăzărescu D
Roum Arch Microbiol Immunol; 1997; 56(1-2):119-24. PubMed ID: 9558980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
